GW26-e1825 Regulation of lipid metabolism and inflammation response by Danqi Pill through PPARα in coronary heart disease

Tianjiao Shi,Qiyan Wang,Chun Li,Jing Wang,Yuan Cao,Wei Wang,Yong Wang

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2015）

引用 0|浏览6

暂无评分

摘要

Lipid metabolism disorders and inflammation response play important roles in the pathogenesis of coronary heart disease (CHD). Danqi Pill (DQP) is prescribed routinely in the treatment of CHD. DQP has both anti-inflammatory and lipid-lowering effects. However, its pharmacological mechanisms are not

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要